Treatment-Related Radiation Toxicity Among Cervical Cancer Patients.

Area of Science:

• Oncology
• Radiation Oncology
• Clinical Research

Background:

• Cervical cancer treatment often involves radiation therapy.
• Severe late toxicity is a significant concern for patients undergoing radiotherapy.
• Identifying associated factors is crucial for improving patient outcomes.

Purpose of the Study:

• To determine the incidence of severe late toxicity in women treated for cervical cancer with radiation.
• To identify demographic and treatment-related factors associated with severe late toxicity.

Main Methods:

• Retrospective review of 179 cervical cancer patients treated with radiation from 2005-2017.
• Analysis of demographic data, comorbidities, treatment details, and toxicity outcomes.
• Comparison of patients with and without severe late gastrointestinal toxicity (SLGIT), severe late genitourinary toxicity (SLGUT), or any toxicity (AT).

Main Results:

• The overall incidence of any toxicity (AT) was 21.2%, with SLGIT at 17.3% and SLGUT at 10%.
• Factors associated with AT included lower body mass index, white race, and active smoking during treatment.
• Higher cumulative radiation dose to the clinical target volume was linked to SLGIT.

Conclusions:

• Radiation toxicity in cervical cancer patients is associated with lower BMI, white race, and smoking.
• Despite technological advancements, radiotherapy toxicity remains a challenge.
• Further interventions are necessary to mitigate treatment-related toxicity burdens.